- Generic name
- Etoricoxib
- Strength
- 120 mg
- Dosage form
- Tablet
- Manufactured by
- Bristol Pharma Ltd.
Etoricoxib-120 Tablet
About Etoricoxib-120 Tablet
Etoricoxib-120 comes as a tablet with 120 mg of Etoricoxib, from Bristol Pharma Ltd. Etoricoxib-120 120 mg tablet is used for the relief of symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.
There are 90 brands of Etoricoxib listed in Bangladesh. The lowest listed price is Retoz 90 mg Tablet at ৳ 1 per unit.
What is Etoricoxib-120 Tablet?
Etoricoxib-120 120 mg tablet is a medicine made by Bristol Pharma Ltd. Its active ingredient is Etoricoxib, which works by targeting an enzyme involved in pain and inflammation in the body. Medicines in this group are used to relieve symptoms such as pain and inflammation in a number of joint and muscle conditions. The dose and length of treatment are decided by your doctor, who will consider your condition and health history.
Uses of Etoricoxib-120
Etoricoxib-120 120 mg tablet is used for the relief of symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It helps reduce pain and signs of inflammation. Ask your doctor what your course is for and how long it should last.
How to use Etoricoxib-120
Swallow with water; you can ask your pharmacist whether to take it with food. Etoricoxib-120 is taken by mouth. Take Etoricoxib-120 tablet exactly as your doctor prescribes. The dose and how long you take it are decided by your doctor, based on your condition and other health factors. Do not change the amount or stop on your own.
Side effects of Etoricoxib-120
Side effects may include palpitation, fatigue, flu-like symptoms, or bruising. Less common effects include dry mouth, taste changes, mouth ulcers, appetite or weight changes, chest pain, flushing, cough, shortness of breath, nosebleeds, anxiety, and muscle or joint pain. Tell your doctor if any effect troubles you.
Safety and precautions
Etoricoxib-120 should not be used by anyone with a known allergy to Etoricoxib-120ricoxib or any of its ingredients. It is not for use during pregnancy or breastfeeding. Etoricoxib is not suitable for everyone. Your doctor will decide if it is safe for you.
Frequently asked questions
What is Etoricoxib-120 used for?
Etoricoxib-120 120 mg tablet is used for the relief of symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It helps reduce pain and signs of inflammation.
How is Etoricoxib-120 used?
Swallow with water; you can ask your pharmacist whether to take it with food. Etoricoxib-120 is taken by mouth.
Can Etoricoxib-120 cause side effects?
Side effects may include palpitation, fatigue, flu-like symptoms, or bruising. Less common effects include dry mouth, taste changes, mouth ulcers, appetite or weight changes, chest pain, flushing, cough, shortness of breath, nosebleeds, anxiety, and muscle or joint pain.
Can I use Etoricoxib-120 in pregnancy or while breastfeeding?
Etoricoxib-120 should not be used by anyone with a known allergy to Etoricoxib-120ricoxib or any of its ingredients. It is not for use during pregnancy or breastfeeding.
Also available as
Indications
- Osteoarthritis (OA)
- Rheumatoid arthritis (RA)
- Ankylosing spondylitis, and
- The pain and signs of inflammation associated with acute gouty arthritis.
- For the short-term treatment of moderate pain associated with dental surgery.
Pharmacology
Dosage & Administration
- Osteoarthritis: The recommended dose is 30 mg once daily. In some patients with insufficient relief from symptoms, an increased dose of 60 mg once daily may increase efficacy.
- Rheumatoid arthritis: The recommended dose is 90 mg once daily.
- Ankylosing spondylitis: The recommended dose is 90 mg once daily.
- Acute gouty arthritis: The recommended dose is 120 mg once daily. In clinical trials for acute gouty arthritis, Etoricoxib was given for 8 days.
- Postoperative dental surgery pain: The recommended dose is 90 mg once daily, limited to a maximum of 3 days.
Interaction
- Oral anticoagulants: In subjects stabilized on chronic warfarin therapy, the administration of Etoricoxib was associated with an increase in prothrombin time.
- Diuretics, ACE inhibitors and Angiotensin II Antagonists: NSAIDs may reduce the effect of diuretics and other antihypertensive drugs.
- Acetylsalicylic Acid: Etoricoxib can be used concomitantly with acetylsalicylic acid at doses used for cardiovascular prophylaxis (low-dose acetylsalicylic acid).
- Ciclosporin and tacrolimus: Although this interaction has not been studied with Etoricoxib, coadministration of ciclosporin or tacrolimus with any NSAID may increase the nephrotoxic effect of ciclosporin or tacrolimus.
- Lithium: NSAIDs decrease lithium renal excretion and therefore increase lithium plasma levels.
Contraindications
- Hypersensitivity to the active substance or to any of the excipients.
- Active peptic ulceration or active gastro-intestinai (Gl) bleeding.
- Patients who have experienced bronchospasm, acute rhinitis, nasal polyps, angioneurotic oedema, urticaria, or allergic-type reactions after taking acetylsalicylic acid or NSAIDs including COX-2 (cyclooxygenase-2) inhibitors.
- Pregnancy and lactation.
- Severe hepatic dysfunction (serum albumin <25 g/l or Child-Pugh score 10).
- Estimated renal creatinine clearance <30 ml/min.
- Children and adolescents under 16 years of age.
- Inflammatory bowel disease.
- Congestive heart failure (NYHA ll-IV).
- Patients with hypertension whose blood pressure is persistently elevated above 140/90 mmHg and has not been adequately controlled.
- Established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease.
Side Effects
Pregnancy & Lactation
Precautions & Warnings
- Caution is advised with treatment of patients most at risk of developing a gastrointestinal complication with NSAIDs; the elderly, patients using any other NSAID or acetylsalicylic acid concomitantly or patients with a prior history of gastrointestinal disease, such as ulceration and Gl bleeding.
- Patients with significant risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking) should only be treated with Etoricoxib after careful consideration.
- Administration of Etoricoxib may cause a reduction in prostaglandin formation and, secondarily, in renal blood flow, and thereby impair renal function. Monitoring of renal function in such patients should be considered.
- Caution should be exercised in patients with a history of cardiac failure, left ventricular dysfunction, or hypertension and in patients with pre-existing edema from any other reason.
- Any patients with symptoms and/or signs suggesting liver dysfunction, or in whom an abnormalliver function test has occurred, should be monitored. If signs of hepatic insufficiency occur, or if persistently abnormal liver function tests (three times the upper limit of normal) are detected, Etoricoxib should be discontinued.
- Etoricoxib should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity.
- Etoricoxib may mask fever and other signs of inflammation. Caution should be exercised when co-administering Etoricoxib with warfarin or other oral anticoagulants.
Overdose Effects
Storage Conditions
Alternative brands of Etoricoxib
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.